2554:
Whole Exome Sequencing Should Be Done For Every Abnormal Newborn Screen
Immune Mechanisms
Saturday, March 3, 2018: 12:30 PM-1:30 PM
Convention Center, South Concourse, Level 3, S310AB
1.00 CME/CE
Pro/Con Debate
Moderator:
Jennifer Heimall, MD
Primary Pro Speakers:
Sergio Rosenzweig, MD
Primary Con Speakers:
Ramsay L. Fuleihan, MD FAAAAI

Learning Objectives:
  1. Discuss the role for genetic diagnosis in SCID
  2. Relate the cost and timing of genetic testing to the risk and benefit for SCID therapy
  3. Discuss the effect of genetic diagnosis on HSCT planning (source and conditioning)
See more of: Session